Astrazeneca chairman add 6,000 shares
Abrdn Property Income Trust Limited
51.50p
16:45 03/05/24
AstraZeneca
12,050.00p
16:49 03/05/24
Banks
4,215.47
16:54 03/05/24
Barclays
202.35p
16:40 03/05/24
Carpetright
4.96p
16:35 22/01/20
Devro
329.00p
17:15 13/04/23
Food Producers & Processors
8,125.63
16:54 03/05/24
FTSE 100
8,213.49
16:59 03/05/24
FTSE 350
4,515.50
16:54 03/05/24
FTSE All-Share
4,469.09
17:14 03/05/24
FTSE Small Cap
6,590.64
16:59 03/05/24
General Retailers
3,936.57
16:54 03/05/24
Pharmaceuticals & Biotechnology
23,112.61
16:54 03/05/24
Real Estate Investment & Services
2,297.70
16:54 03/05/24
Improved full year guidance ensured Astrazeneca shares proved popular with board members this week, with chairman Leif Johansson adding a further 6,000 shares to his stake in the drugs maker.
The shares were acquired at SEK 502.95 per share, equal to 4,347p each.
Purchases were also made by non-executive directors Geneviève Berger, Shriti Vadera and senior non-executive director John Varley.
Vadera and Varley each added 3,500 shares, paying 4,328p and 4,370p, respectively. Berger purchased 300 shares at 4,324p.
The purchases came after the company upped its guidance for the year after delivering a 4% increase in second quarter revenue to $6.4bn, ahead of expectations.
Half year turnover at the drugs giant climbed 3%, driven by gains across all five of its growth areas, particularly Diabetes, which jumped 128% following the successful integration of the BMS assets and the launch of Farxiga in the US.
For the full year, revenue is expected to be in line with the prior year at constant exchange rates (CER), compared to previous guidance of a low-to-mid single digit percentage decline.
Top Director Buys
AstraZeneca (AZN)
Director name: Mr Leif Johansson
Amount purchased: 6,000 @ 4,355.23p
Value: £261,314
AstraZeneca (AZN)
Director name: Mr John Varley
Amount purchased: 3,500 @ 4,370.00p
Value: £152,950
AstraZeneca (AZN)
Director name: Baroness Shriti Vadera
Amount purchased: 3,500 @ 4,328.00p
Value: £151,480
Maven Income and Growth VCT 5 (MIG5)
Director name: Mr Allister G Langlands
Amount purchased: 100,000 @ 30.00p
Value: £30,000
Barclays (BARC)
Director name: Sir David A Walker
Amount purchased: 11,522 @ 225.79p
Value: £26,016
Standard Life Investments Property Income Trust Ltd. (SLI)
Director name: Mr Robert Peto
Amount purchased: 27,435 @ 72.90p
Value: £20,000
ULS Technology (ULS)
Director name: Mr John Williams
Amount purchased: 48,291 @ 41.00p
Value: £19,799
Standard Life Investments Property Income Trust Ltd. (SLI)
Director name: Mr Richard Barfield
Amount purchased: 20,000 @ 72.90p
Value: £14,580
AstraZeneca (AZN)
Director name: Professor Genevieve Berger
Amount purchased: 300 @ 4,324.00p
Value: £12,972
Barclays (BARC)
Director name: Mr Reuben Jeffery III
Amount purchased: 5,280 @ 225.79p
Value: £11,922
Top Director Sells
British American Tobacco (BATS)
Director name: Mr Nicandro Durante
Amount sold: 72,485 @ 3,535.00p
Value: £2,562,345
Carpetright (CPR)
Director name: Mr Martin Harris
Amount sold: 90,000 @ 525.00p
Value: £472,500
Devro (DVO)
Director name: Mr Peter Page
Amount sold: 37,565 @ 253.44p
Value: £95,205
NR